R
rapamycin
ProductHeard in 6 episodes across 5 shows since Sep 2026
A prescription immunosuppressant and mTOR inhibitor studied for potential effects on cellular aging and longevity; it is not primarily a cosmetic skincare product.
Discussed inMarkets50%Health & Science50%
Episodes
6
across 5 shows
This week
0
episodes on 0 shows
Share of the conversation
Mentions of rapamycin per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 3 | 0.01‰ | 1 |
| Sep 22 | 0.01‰ | 1 |
| Sep 28 | 0.03‰ | 2 |
| Oct 15 | 0.02‰ | 2 |
| Oct 30 | 0.01‰ | 1 |
| Nov 16 | 0.01‰ | 1 |
Email alert
Email me when rapamycin comes up on a podcast
One email a week at most, with the new episodes that mention rapamycin. Free, no account needed, unsubscribe in one click.
Episodes
6 episodes featuring rapamycin, newest first
- Nov 16, 2026
Mitochondria do more than power cells—and supplements may not helpThe Peter Attia DriveNov 16, 2026 - Oct 30, 2026
Biotech weighs AI promise against biology’s stubborn bottlenecksBiotech HangoutOct 30, 2026 - Oct 15, 2026
Longevity medicine collides with evidence and ethicsBehind the BastardsOct 15, 2026 - Sep 28, 2026
Bimagrumab exposes the hard economics of drug developmentThe Peter Attia DriveSep 28, 2026 - Sep 22, 2026
Lifestyle may outrun Alzheimer’s drugsThe Ultimate Human with Gary BreckaSep 22, 2026 - Sep 3, 2026
Protein restriction promises longevity, but human evidence falls shortScience VsSep 3, 2026